Farallon Capital Management LLC Cerevel Therapeutics Holdings, Inc. Transaction History

Farallon Capital Management LLC

  • $19.9 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$38.96 - $42.75 $4.95 Million - $5.43 Million
127,000 Added 11.95%
1,190,000 $48.7 Million
Q1 2024

Aug 14, 2024
BUY
$40.88 - $43.27 $43.5 Million - $46 Million
1,063,000 New
1,063,000 $44.9 Billion
Q4 2023

Feb 14, 2024
BUY
$20.27 - $42.44 $11.5 Million - $24.1 Million
567,321 New
567,321 $24.1 Million

Others Institutions Holding CERE

# of Institutions
9
Shares Held
5.01M
Call Options Held
3.3K
Put Options Held
0
View Full List

About Cerevel Therapeutics Holdings, Inc.

CERE Quotes by TradingView
  • Ticker CERE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 155,752,000
  • Description
  • Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...
More about CERE
Track This Portfolio

Track Farallon Capital Management LLC Portfolio

Follow Farallon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email